Rankings
▼
Calendar
AUPH Q3 2019 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$230,000
-38.7% YoY
Gross Profit
-$18M
-7635.2% margin
Operating Income
-$24M
-10439.6% margin
Net Income
-$19M
-8277.0% margin
EPS (Diluted)
$-0.21
QoQ Revenue Growth
+693.1%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$151M
Total Liabilities
$27M
Stockholders' Equity
$124M
Cash & Equivalents
$135M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$230,000
$375,000
-38.7%
Gross Profit
-$18M
-$11M
-62.9%
Operating Income
-$24M
-$14M
-70.2%
Net Income
-$19M
-$18M
-3.8%
← FY 2019
All Quarters
Q4 2019 →